Sherbrooke Park Advisers’s Pacira BioSciences PCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-29,342	Closed	-$442K	–	1065
2024 Q3	$442K	Buy	29,342 +13,005	+80%	+$196K	0.1%	360
2024 Q2	$467K	Buy	+16,337	New	+$467K	0.08%	444
2023 Q4	–	Sell	-8,951	Closed	-$275K	–	625
2023 Q3	$275K	Buy	+8,951	New	+$275K	0.09%	344